Search results

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 21 December 2020

SPCs updated to advise that limited published literature indicates azithromycin is present in human milk at an estimated highest median daily dose of 0.1 to 0.7 mg/kg/day; and no serious adverse...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 21 December 2020

Optic neuritis (inflammation of optic nerve) added as an undesirable effect of treatment with unknown frequency.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 18 December 2020

Decreased appetite (very common frequency) and toxic epidermal necrolysis (unknown frequency) added to SPC as adverse events.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 18 December 2020

SPC includes a warning for cholangitis. Cases have been reported as a complication of cholelithiasis in in the post-marketing setting. Ultrasonic examination of the gallbladder before, and at about...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 20 December 2020

Sjogren’s syndrome has been added as an adverse event (frequency rare for monotherapy and in combination with chemotherapy and uncommon in combination with axitinib).

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 18 December 2020

SPC updated to include information on peak LFT elevations being generally higher in paediatric patients than in older patients. A new 75mg tablet has also been introduced.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 30 December 2020

SPC now provides details for use in the new indication of induction of remission in active microscopic colitis. The recommended schedule is 1 tablet (9 mg) daily for up to 8 weeks.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 06 November 2020

Ozanimod, is an oral sphingosine-1-phosphate receptor modulator, licensed for the treatment of adults with relapsing remitting multiple sclerosis with active disease as defined by clinical or imaging...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 06 November 2020

SPC updated to note the pre-filled syringe and pre-filled pen are only available as a 40mg dose; thus, it is not possible to administer them to paediatric patients requiring a smaller dose. If an...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 05 November 2020

This new presentation of bilastine (20mg tablets and 10mg orodispersible tablets also available) is licensed for the symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) ...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)